Table 1.
The relationship between clinicopathological parameters and miR-183 expression in primary gastric adenocarcinoma
| Clinicopathological Parameters | Patients (n) % | Expression level of miR-183 T/F Test P | |||
|---|---|---|---|---|---|
| Gender | 1.049 | 0.299 | |||
| Male | 40 | 77% | -3.428±0.215 | ||
| Female | 12 | 23% | -3.938±0.531 | ||
| Age (Y) | 0.143 | 0.887 | |||
| ≤60 | 25 | 48% | -3.576±0.227 | ||
| >60 | 27 | 52% | -3.517±0.339 | ||
| Location of tumor | 0.065 | 0.978 | |||
| Upper stomach | 16 | 31% | -3.447±0.415 | ||
| Middle stomach | 7 | 13% | -3.750±0.628 | ||
| Lower stomach | 24 | 46% | -3.554±0.279 | ||
| Mixed | 5 | 10% | -3.537±0.715 | ||
| Tumor size | 0.731 | 0.469 | |||
| ≤5 cm | 13 | 25% | -3.285±0.420 | ||
| >5 cm | 39 | 75% | -3.633±0.237 | ||
| Grade of differentiation | 0.286 | 0.776 | |||
| Well and moderate | 31 | 60% | -3.594±0.274 | ||
| Poor and not | 21 | 40% | -3.474±0.315 | ||
| Depth of invasion | 1.779 | 0.081 | |||
| T1+T2 | 12 | 23% | -2.893±0.235 | ||
| T3+T4 | 40 | 77% | -3.741±0.250 | ||
| Lymph node metastasis | 2.945 | 0.005* | |||
| Negative | 12 | 23% | -2.518±0.352 | ||
| Positive | 40 | 77% | -3.854±0.225 | ||
| Distant metastasis | 0.962 | 0.341 | |||
| Negative | 49 | 94% | -3.497±0.215 | ||
| Positive | 3 | 6% | -4.343±0.287 | ||
| TNM stage | 2.829 | 0.007* | |||
| I+II | 16 | 46 | -2.730±0.283 | ||
| III+IV | 36 | 33 | -3.908±0.247 | ||
*
P<0.05, statistical significance.